Literature DB >> 20683710

Prevalence of risk factors for fractures and use of DXA scanning in Danish women. A regional population-based study.

K H Rubin1, B Abrahamsen, A P Hermann, M Bech, J Gram, K Brixen.   

Abstract

SUMMARY: To determine the relationship between risk factors and use of DXA scans. Our study showed a relatively high use of DXA in low-risk women and the relatively low coverage in women with multiple risk factors. Moreover, distance to DXA clinics, age, and socio-economic factors are associated with the use of DXA.
INTRODUCTION: To determine the relationship between risk factors for fracture and use of DXA scans in Danish women in relation to distance to DXA clinics and socio-economic factors.
METHODS: From the Danish National Civil Register we randomly selected 5,000 women aged 40-90 years living in the region of Southern Denmark to receive a mailed questionnaire concerning risk factors for fractures.
RESULTS: The respondents rate was 84% and 77% of the invited population were available for analysis. A total of 10.3% of the women without risk factors and only 36% of the women with three or more risk factors had a history of DXA. The likelihood of a history of DXA was higher with increasing FRAX(™) 10-year risk; i.e., 8.7% and 30.2% in patients with a 10-year fracture risk of 0-14.9% and 25-100%, respectively. In women with less than 10 km to nearest DXA facility, 20.2% had a history of DXA, while 11.5% of those with more than 40 km to the nearest scanner had a history of DXA. Logistic regression analysis showed that distance, fracture risk, oral glucocorticoids, low-energy fracture, conditions associated with secondary osteoporosis, low BMI, history of falls, age 65-79 years, spouse status, and income were significantly associated with having a history of DXA.
CONCLUSIONS: Our study showed a relatively high use of DXA in low-risk women and the relatively low coverage in women with multiple risk factors. Moreover, distance to DXA clinics, age, and a number of socio-economic factors are associated with the use of DXA.

Entities:  

Mesh:

Year:  2010        PMID: 20683710     DOI: 10.1007/s00198-010-1348-5

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  21 in total

1.  National Osteoporosis Foundation 2008 Clinician's Guide to Prevention and Treatment of Osteoporosis and the World Health Organization Fracture Risk Assessment Tool (FRAX): what they mean to the bone densitometrist and bone technologist.

Authors:  Nelson B Watts; E Michael Lewiecki; Paul D Miller; Sanford Baim
Journal:  J Clin Densitom       Date:  2008-06-18       Impact factor: 2.617

2.  Bone: Using FRAX wisely: lessons from Switzerland and beyond.

Authors:  E Michael Lewiecki
Journal:  Nat Rev Endocrinol       Date:  2010-03       Impact factor: 43.330

3.  Determinants of recovery 12 months after hip fracture: the importance of psychosocial factors.

Authors:  J M Mossey; E Mutran; K Knott; R Craik
Journal:  Am J Public Health       Date:  1989-03       Impact factor: 9.308

Review 4.  The socioeconomic burden of fractures: today and in the 21st century.

Authors:  O Johnell
Journal:  Am J Med       Date:  1997-08-18       Impact factor: 4.965

Review 5.  Body mass index as a predictor of fracture risk: a meta-analysis.

Authors:  C De Laet; J A Kanis; A Odén; H Johanson; O Johnell; P Delmas; J A Eisman; H Kroger; S Fujiwara; P Garnero; E V McCloskey; D Mellstrom; L J Melton; P J Meunier; H A P Pols; J Reeve; A Silman; A Tenenhouse
Journal:  Osteoporos Int       Date:  2005-06-01       Impact factor: 4.507

Review 6.  Screening for osteoporosis in the adult U.S. population: ACPM position statement on preventive practice.

Authors:  Lionel S Lim; Laura J Hoeksema; Kevin Sherin
Journal:  Am J Prev Med       Date:  2009-04       Impact factor: 5.043

7.  FRAX and the assessment of fracture probability in men and women from the UK.

Authors:  J A Kanis; O Johnell; A Oden; H Johansson; E McCloskey
Journal:  Osteoporos Int       Date:  2008-02-22       Impact factor: 4.507

8.  Smoking and fracture risk: a meta-analysis.

Authors:  J A Kanis; O Johnell; A Oden; H Johansson; C De Laet; J A Eisman; S Fujiwara; H Kroger; E V McCloskey; D Mellstrom; L J Melton; H Pols; J Reeve; A Silman; A Tenenhouse
Journal:  Osteoporos Int       Date:  2004-06-03       Impact factor: 4.507

9.  The geographic availability and associated utilization of dual-energy X-ray absorptiometry (DXA) testing among older persons in the United States.

Authors:  J R Curtis; A Laster; D J Becker; L Carbone; L C Gary; M L Kilgore; R S Matthews; M A Morrisey; K G Saag; S B Tanner; E Delzell
Journal:  Osteoporos Int       Date:  2008-12-24       Impact factor: 4.507

10.  Guidelines for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK.

Authors:  J Compston; A Cooper; C Cooper; R Francis; J A Kanis; D Marsh; E V McCloskey; D M Reid; P Selby; M Wilkins
Journal:  Maturitas       Date:  2009-01-08       Impact factor: 4.342

View more
  13 in total

1.  The post-fracture care gap among Canadian First Nations peoples: a retrospective cohort study.

Authors:  W D Leslie; S L Brennan; H J Prior; L M Lix; C Metge; B Elias
Journal:  Osteoporos Int       Date:  2012-01-03       Impact factor: 4.507

2.  Development and validation of a tool for identifying women with low bone mineral density and low-impact fractures: the São Paulo Osteoporosis Risk Index (SAPORI).

Authors:  M M Pinheiro; E T Reis Neto; F S Machado; F Omura; J Szejnfeld; V L Szejnfeld
Journal:  Osteoporos Int       Date:  2011-07-19       Impact factor: 4.507

3.  Non-participation in systematic screening for osteoporosis-the ROSE trial.

Authors:  M J Rothmann; S Möller; T Holmberg; M Højberg; J Gram; M Bech; K Brixen; A P Hermann; C-C Glüer; R Barkmann; K H Rubin
Journal:  Osteoporos Int       Date:  2017-09-05       Impact factor: 4.507

4.  Pattern of use of DXA scans in men: a cross-sectional, population-based study.

Authors:  M Frost; C Gudex; K H Rubin; K Brixen; B Abrahamsen
Journal:  Osteoporos Int       Date:  2011-02-26       Impact factor: 4.507

5.  Use of antiosteoporotic medication in the Danish ROSE population-based screening study.

Authors:  M P Høiberg; K H Rubin; T Holmberg; M J Rothmann; S Möller; J Gram; M Bech; K Brixen; A P Hermann
Journal:  Osteoporos Int       Date:  2019-03-26       Impact factor: 4.507

6.  FRAX provides robust fracture prediction regardless of socioeconomic status.

Authors:  S L Brennan; W D Leslie; L M Lix; H Johansson; A Oden; E McCloskey; J A Kanis
Journal:  Osteoporos Int       Date:  2013-11-05       Impact factor: 4.507

7.  Bisphosphonates to reduce bone fractures in stage 3B+ chronic kidney disease: a propensity score-matched cohort study.

Authors:  Danielle E Robinson; M Sanni Ali; Victoria Y Strauss; Leena Elhussein; Bo Abrahamsen; Nigel K Arden; Yoav Ben-Shlomo; Fergus Caskey; Cyrus Cooper; Daniel Dedman; Antonella Delmestri; Andrew Judge; Muhammad Kassim Javaid; Daniel Prieto-Alhambra
Journal:  Health Technol Assess       Date:  2021-03       Impact factor: 4.014

8.  Development and validation of osteoporosis prescreening model for Iranian postmenopausal women.

Authors:  Nassim Matin; Omidreza Tabatabaie; Abbasali Keshtkar; Kamran Yazdani; Mojgan Asadi
Journal:  J Diabetes Metab Disord       Date:  2015-03-17

9.  Calcaneal quantitative ultrasound and phalangeal radiographic absorptiometry alone or in combination in a triage approach for assessment of osteoporosis: a study of older women with a high prevalence of falls.

Authors:  Katja Thomsen; Jesper Ryg; Anne P Hermann; Lars Matzen; Tahir Masud
Journal:  BMC Geriatr       Date:  2014-12-20       Impact factor: 3.921

10.  Implications of combined ovariectomy/multi-deficiency diet on rat bone with age-related variation in bone parameters and bone loss at multiple skeletal sites by DEXA.

Authors:  Parameswari Govindarajan; Gudrun Schlewitz; Nathalie Schliefke; David Weisweiler; Volker Alt; Ulrich Thormann; Katrin Susanne Lips; Sabine Wenisch; Alexander C Langheinrich; Daniel Zahner; Nasr Y Hemdan; Wolfgang Böcker; Reinhard Schnettler; Christian Heiss
Journal:  Med Sci Monit Basic Res       Date:  2013-02-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.